Related Experiment Video
Updated: Jan 25, 2026

Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers
Published on: September 19, 2022
Light-Triggered PEGylation/dePEGylation of the Nanocarriers for Enhanced Tumor Penetration
Mengxue Zhou1, Hui Huang1, Dongqing Wang1
1CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Multi-disciplinary Research Division, Institute of High Energy Physics and University of Chinese Academy of Sciences (UCAS) , Chinese Academy of Sciences (CAS) , Beijing 100049 , P.R. China.
Abstract:
Nanocarriers-derived anticancer therapeutics typically suffers from poor tumor penetration and suboptimal antitumor efficacy. Although PEGylation improves the stability of nanoparticles and prolongs drug circulation, it further increases the size of nanoparticles and adversely affects the tumor penetration. Here, we developed a light-triggered PEGylation/dePEGylation strategy, whereby near-infrared (NIR)-/pH- dual responsive dePEGylation activates iRGD for tumor targeting. The embedded up-conversion nanoparticles (UCNPs) could efficiently convert NIR to UV-vis which cleaved the linker to remove PEG. NIR-induced dePEGylation remarkably improved vascular extravasation of drugs and deep tumor penetration. Therefore, the stimuli-responsive nanocarriers facilitated the tumor-targeted delivery of drugs through blood circulation and enhanced the antitumor effects.
Insights
This study introduces a novel light-triggered strategy to enhance anticancer drug delivery. By removing a protective layer (PEGylation) using near-infrared light, nanocarriers better penetrate tumors, improving therapeutic effectiveness.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Drug Delivery
Background:
- Nanocarrier-based anticancer drugs often show poor tumor penetration and efficacy.
- PEGylation, while stabilizing nanoparticles, can hinder tumor penetration due to increased size.
Purpose of the Study:
- To develop a light-triggered strategy for enhanced nanocarrier tumor penetration and anticancer efficacy.
- To investigate a dual-responsive (NIR/pH) dePEGylation system activating tumor-targeting moieties.
Main Methods:
- Developed nanocarriers with embedded up-conversion nanoparticles (UCNPs) for NIR to UV-vis conversion.
- Utilized a cleavable linker for light-induced PEG removal (dePEGylation).
- Incorporated iRGD peptide for tumor targeting, activated upon dePEGylation.
Main Results:
- Near-infrared (NIR) light triggered dePEGylation, removing the PEG layer.
- DePEGylation significantly enhanced vascular extravasation and deep tumor penetration.
- The stimuli-responsive nanocarriers demonstrated improved drug delivery and enhanced antitumor effects.
Conclusions:
- Light-triggered dePEGylation is an effective strategy to overcome nanocarrier tumor penetration limitations.
- Dual-responsive nanocarriers improve targeted drug delivery and therapeutic outcomes in tumors.
- This approach offers a promising platform for advanced cancer nanotherapeutics.
Related Concept Videos
Photoreceptors and Plant Responses to Light
Self-Evaluation: Self-Enhancement and Self-Verification
Light Acquisition
Light as Energy
Photons
A photon is a discrete electromagnetic particle or bundle of energy. Photons are characterized by their frequency, wavelength, and amplitude, similar to the properties of a wave. Waves with higher frequencies transmit more energy and have shorter wavelengths than longer wavelengths that transmit...
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement

